References
- Bech-Otschir D, Kraft R, Huang X, et al (2001). COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J, 20, 1630-9. https://doi.org/10.1093/emboj/20.7.1630
- Broker LE, Giaccone G (2002). The role of new agents in the treatment of non-small cell lung cancer. Eur J Cancer, 38, 2347-61. https://doi.org/10.1016/S0959-8049(02)00457-4
- Chen L, Liang Z, Tian Q, et al (2011). Overexpression of LCMR1 is significantly associated with clinical stage in human NSCLC. J Exp Clin Cancer Res, 30, 18. https://doi.org/10.1186/1756-9966-30-18
- Devi G R (2006). siRNA-based approaches in cancer therapy. Cancer Gene Ther, 13, 819-29. https://doi.org/10.1038/sj.cgt.7700931
- Fuchs B, Pritchard DJ (2002). Etiology of osteosarcoma. Clin Orthop, 397, 40-52. https://doi.org/10.1097/00003086-200204000-00007
- Gokgoz N, Wunder JS, Mousses S, et al (2001). Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma. Cancer, 92, 2181-9. https://doi.org/10.1002/1097-0142(20011015)92:8<2181::AID-CNCR1561>3.0.CO;2-3
- Henriksen J, Aagesen TH, Maelandsmo GM, et al (2003). Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasomemediated degradation. Oncogene, 22, 5358-61. https://doi.org/10.1038/sj.onc.1206671
- Luo J, Emanuele MJ, Li D, et al (2009). A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell, 137, 835-48. https://doi.org/10.1016/j.cell.2009.05.006
- Paddison PJ, Hannon GJ (2003). siRNAs and shRNAs: skeleton keys to the human genome. Curr Opin Mol Ther, 5, 217-24.
- Sharma SV, Bell DW, Settleman J, Haber DA (2007). Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer, 7, 169-81. https://doi.org/10.1038/nrc2088
- Singh A, Boldin-Adamsky S, Thimmulappa RK, et al (2008). RNAi-mediated silencing of nuclear factor erythroid-2- related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Res, 68, 7975-84. https://doi.org/10.1158/0008-5472.CAN-08-1401
- Skrzypski M, Dziadziuszko R, Jassem J (2011). MicroRNA in lung cancer diagnostics and treatment. Mutat Res, 17, 25-31.
- van Dartel M, Redeker S, Bras J, Kool M, Hulsebos TJ (2004). Overexpression through amplification of genes in chromosome region 17p11.2 approximately p12 in highgrade osteosarcoma. Cancer Genet Cytogenet, 152, 8-14. https://doi.org/10.1016/j.cancergencyto.2003.09.024
- Wei N, Deng XW (2003). The COP9 signalosome. Annu Rev Cell Dev Biol, 19, 261-86. https://doi.org/10.1146/annurev.cellbio.19.111301.112449
- Yan J, Walz K, Nakamura H, et al (2003). COP9 signalosome subunit 3 is essential for maintenance of cell proliferation in the mouse embryonic epiblast. Mol Cell Biol, 23, 6798-808. https://doi.org/10.1128/MCB.23.19.6798-6808.2003
- Yan T, Wunder JS, Gokgoz N, et al (2007). COPS3 amplification and clinical outcome in osteosarcoma. Cancer, 109, 1870-6. https://doi.org/10.1002/cncr.22595
- Yan T, Tang G, Ren T, et al (2011). RNAi-mediated COPS3 gene silencing inhibits metastasis of osteogenic sarcoma cells. Cancer Gene Ther, 18, 450-6. https://doi.org/10.1038/cgt.2011.16
Cited by
- Alpinetin promotes Bax translocation, induces apoptosis through the mitochondrial pathway and arrests human gastric cancer cells at the G2/M phase vol.7, pp.3, 2012, https://doi.org/10.3892/mmr.2012.1243
- Upregulation of the Kank1 gene-induced brain glioma apoptosis and blockade of the cell cycle in G0/G1 phase vol.44, pp.3, 2014, https://doi.org/10.3892/ijo.2014.2247
- A Meta-Analysis of Multiple Matched Copy Number and Transcriptomics Data Sets for Inferring Gene Regulatory Relationships vol.9, pp.8, 2014, https://doi.org/10.1371/journal.pone.0105522
- Roles of Multifunctional COP9 Signalosome Complex in Cell Fate and Implications for Drug Discovery vol.232, pp.6, 2017, https://doi.org/10.1002/jcp.25696
- Development of Small RNA Delivery Systems for Lung Cancer Therapy vol.16, pp.12, 2015, https://doi.org/10.3390/ijms16035254
- Novel oncogene COPS3 interacts with Beclin1 and Raf-1 to regulate metastasis of osteosarcoma through autophagy vol.37, pp.1, 2018, https://doi.org/10.1186/s13046-018-0791-6